CN112168719A

CN112168719A - Microcapsule smoothing toner and preparation method thereof

Info

Publication number: CN112168719A
Application number: CN202010881144.8A
Authority: CN
Inventors: 周志俊; 陈永兵; 杨仕贵
Original assignee: Rongding Guangdong Biotechnology Co Ltd
Current assignee: Rongding Guangdong Biotechnology Co Ltd
Priority date: 2020-08-27
Filing date: 2020-08-27
Publication date: 2021-01-05

Abstract

The invention discloses microcapsule smoothing toner and a preparation method thereof, and the microcapsule smoothing toner comprises 4-6% of beta-CD solution, 5-7% of mei teng fruit oil, 3-9% of stearic acid, 2-4% of hexadecanol, 5-10% of isopropyl palmitate, 2-6% of lanolin, 0.5-2.5% of jasmine extract, 1-3% of hyaluronic acid, 0.5-1% of polyglutamic acid, 1-3% of collagen, 0.05-0.1% of essence, 0.2-0.4% of urea aldehyde, 0.5-2% of cactus extract, 2-3% of aloe extract and the balance of deionized water, and relates to the technical field of cosmetics. The natural plant extract adopted by the invention is mild and non-irritant to skin, has no toxic or side effect, can clean skin, supplement nutrient substances, preserve moisture and lock water, moisten skin and relieve various skin sensitivity problems; the natural plant extract can rapidly and smoothly shrink pores, disrupt virus and bacteria, shrink rough pores and achieve the function of shrinking pores.

Description

Microcapsule smoothing toner and preparation method thereof

Technical Field

The invention relates to the technical field of cosmetics, in particular to microcapsule smoothing toner and a preparation method thereof.

Background

Acne is a common inflammatory disease of skin, commonly known as whelk, comedo and pimple, and ancient traditional Chinese medicine is named as face sore and acne. It is usually found in the abundant sebaceous glands of the head, face, neck, chest and back of adolescent male and female. Acne has various pathogenic factors, the pathogenesis of the acne is unknown at present, and a plurality of medicines and methods for treating the acne are available at present, but the acne has poor effect, is developed at good time, has scars or pigmentation after healing, and influences the external appearance of a patient.

The water deficiency is one of the causes of skin sensitivity and even acne, when the moisture of the surface layer of the skin, namely the cuticle, reaches 20 to 25 percent and the water content is sufficient, the skin is soft, smooth and free from fine lines, the hand feeling is full of elasticity, and the resistance to sensitization factors such as seasonal changes, temperature changes, environmental factors and the like is enhanced. However, with age and poor skin care, the water in the stratum corneum is lost, and when the content is less than 10%, the skin becomes dry, fine lines, tight, rough, desquamation, redness and sensitivity. The existing skin softening aquatic products in the market are mainly directed at surface skin, and the used raw materials are mainly artificially synthesized chemical raw materials, so that the skin softening aquatic products have certain toxicity, and the moisturizing and water locking effects are difficult to achieve. In recent years, cosmetics containing natural plant products, namely the bamboo shoots in spring after rain, appear on the market, the characteristics of being green, natural, environment-friendly and harmless are greatly favored by consumers, and the cosmetics have wide market prospects for development and development.

Disclosure of Invention

Aiming at the defects of the prior art, the invention provides a microcapsule smoothing toner and a preparation method thereof, and solves some problems of the prior art.

In order to achieve the purpose, the invention is realized by the following technical scheme: a microcapsule smoothing toner comprises 4% -6% of a beta-CD solution, 5% -7% of a plukenetia volubilis fruit oil, 3% -9% of stearic acid, 2% -4% of cetyl alcohol, 5% -10% of isopropyl palmitate, 2% -6% of lanolin, 0.5% -2.5% of a jasmine extracting solution, 1% -3% of hyaluronic acid, 0.5% -1% of polyglutamic acid, 1% -3% of collagen, 0.05% -0.1% of essence, 0.2% -0.4% of urea aldehyde, 0.5% -2% of a cactus extracting solution, 2% -3% of an aloe extracting solution and the balance of deionized water.

A preparation method of microcapsule smoothing toner comprises the steps of S1, preparing beta-CD solution, heating and stirring to completely dissolve;

s2, completely emulsifying the plukenetia volubilis linneo oil by using an emulsifier, wherein the mass of the emulsifier is 10% -20% of that of the plukenetia volubilis linneo oil; adding the beta-CD solution into the completely emulsified plukenetia volubilis linneo oil after the beta-CD solution is cooled, wherein the mass ratio of the beta-cyclodextrin to the plukenetia volubilis linneo oil in the beta-CD solution is 8: 1-5, and stirring for reaction to obtain plukenetia volubilis linneo oil microcapsules;

step S3, weighing water phase raw materials and oil phase raw materials,

the oil phase raw materials comprise the following substances in parts by weight: 3% -9% of stearic acid, 2% -4% of cetyl alcohol, 5% -10% of isopropyl palmitate, 2% -6% of lanolin, 1% -3% of methyl paraben, 2% -8% of triethanolamine and 5% -10% of glycerol;

5-7% of calamus margaritae oil, 3-9% of stearic acid, 2-4% of hexadecanol, 5-10% of isopropyl palmitate, 2-6% of wool grease, 0.5-2.5% of jasmine extracting solution, 1-3% of hyaluronic acid, 0.5-1% of polyglutamic acid, 1-3% of collagen, 0.05-0.1% of essence and 0.2-0.4% of urea aldehyde are weighed according to the proportion, the mixture is added into a mixing tank to be mixed and dissolved, and the mixture is uniformly stirred for later use;

continuously heating 0.5-2% of the palm extract, 2-3% of the aloe extract and the balance of deionized water to 75-80 ℃ under the stirring of 20-30 r/min, and sterilizing at constant temperature for 20 minutes for later use;

slowly pumping the oil phase into the water phase, scraping the wall, stirring, increasing the rotation speed to 30-60 r/min, stirring for 2-3 min, and starting a high-speed homogenizer for processing;

and step S4, dispersing the microcapsules in the homogenized essence, and uniformly stirring to obtain the product.

Preferably, the concentration of the beta-CD solution is 15%.

Preferably, the stirring temperature of step S2 is 110 ℃.

Preferably, a preservative is added in the step S4, and the preservative is hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer.

Preferably, an emulsifier is added in the step S4, and the emulsifier is hydroxyethyl acrylate.

Advantageous effects

The invention provides a microcapsule smoothing toner and a preparation method thereof. The natural plant extract adopted by the invention is mild and non-irritant to skin, has no toxic or side effect, can clean skin, supplement nutrient substances, preserve moisture and lock water, moisten skin and relieve various skin sensitivity problems; the natural plant extract can rapidly and smoothly shrink pores, disrupt virus and bacteria, shrink rough pores and achieve the function of shrinking pores.

Detailed Description

The technical solutions in the embodiments of the present invention are clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.

The invention provides a technical scheme that: a microcapsule smoothing toner and its preparation method are provided.

Example (b):

a microcapsule smoothing toner comprises 4% -6% of a beta-CD solution, 5% -7% of a plukenetia volubilis fruit oil, 3% -9% of stearic acid, 2% -4% of cetyl alcohol, 5% -10% of isopropyl palmitate, 2% -6% of lanolin, 0.5% -2.5% of a jasmine extracting solution, 1% -3% of hyaluronic acid, 0.5% -1% of polyglutamic acid, 1% -3% of collagen, 0.05% -0.1% of essence, 0.2% -0.4% of urea aldehyde, 0.5% -2% of a cactus extracting solution, 2% -3% of an aloe extracting solution and the balance of deionized water.

The mei teng guo oil is edible oil extracted from mei teng guo nuts, does not contain any toxin and substances harmful to human bodies, and has the content of unsaturated fatty acid of more than 90 percent, wherein the content of linolenic acid is 48 percent, the content of linoleic acid is 35 percent, and the content of oleic acid is 9 percent.

Cactus as a medicinal plant in China is first recorded in Ben Cao gang mu Shi Yi (compendium of materia Medica) written by Zhao Ming Dynasty, which is recorded as: the cactus is light in taste and cold in nature, has the effects of promoting qi and blood circulation, clearing away heat and toxic materials, relieving swelling and pain, invigorating spleen, relieving diarrhea, tranquilizing mind and promoting urination, and can be orally taken and externally used for treating various diseases. Cactus can be used for treating furuncle, abdominal pain, stomach ache, abdominal mass, acute dysentery, intestinal hemorrhoid, hemorrhage, and asthma.

The aloe polysaccharide and vitamins have good nourishing, moistening and whitening effects on human skin. Aloe barbadensis Miller is the fresh aloe leaf most suitable for direct skin care, i.e., Aloe barbadensis Miller, and has skin astringent, softening, moisturizing, antiinflammatory, and bleaching effects. It also has effects in relieving sclerosis and keratinization, improving scar, preventing wrinkle, eye pouch, and cutis laxa, keeping skin moist and delicate, treating skin inflammation, and treating acne, freckle, acne, scald, knife wound, and insect bite. It is also effective for hair, and can keep hair moist and smooth and prevent alopecia.

A method for preparing microcapsule smoothing toner comprises preparing beta-CD solution, heating and stirring to dissolve completely; emulsifying the plukenetia volubilis linneo oil completely by using an emulsifier, wherein the mass of the emulsifier is 10% -20% of that of the plukenetia volubilis linneo oil; adding the beta-CD solution into the completely emulsified plukenetia volubilis linneo oil after the beta-CD solution is cooled, wherein the mass ratio of the beta-cyclodextrin to the plukenetia volubilis linneo oil in the beta-CD solution is 8: 1-5, and stirring for reaction to obtain plukenetia volubilis linneo oil microcapsules; weighing water-phase raw materials and oil-phase raw materials, wherein the oil-phase raw materials comprise the following substances in parts by weight: 3% -9% of stearic acid, 2% -4% of cetyl alcohol, 5% -10% of isopropyl palmitate, 2% -6% of lanolin, 1% -3% of methyl paraben, 2% -8% of triethanolamine and 5% -10% of glycerol; 5-7% of calamus margaritae oil, 3-9% of stearic acid, 2-4% of hexadecanol, 5-10% of isopropyl palmitate, 2-6% of wool grease, 0.5-2.5% of jasmine extracting solution, 1-3% of hyaluronic acid, 0.5-1% of polyglutamic acid, 1-3% of collagen, 0.05-0.1% of essence and 0.2-0.4% of urea aldehyde are weighed according to the proportion, the mixture is added into a mixing tank to be mixed and dissolved, and the mixture is uniformly stirred for later use; continuously heating 0.5-2% of the palm extract, 2-3% of the aloe extract and the balance of deionized water to 75-80 ℃ under the stirring of 20-30 r/min, and sterilizing at constant temperature for 20 minutes for later use; slowly pumping the oil phase into the water phase, scraping the wall, stirring, increasing the rotation speed to 30-60 r/min, stirring for 2-3 min, and starting a high-speed homogenizer for processing; dispersing the microcapsules in the homogenized essence, and uniformly stirring to obtain the product.

Preferably, the concentration of the beta-CD solution is 15%.

Preferably, the stirring temperature of step S2 is 110 ℃.

Preferably, an emulsifier is added in step S4, and the emulsifier is hydroxyethyl acrylate.

It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. Without further limitation. The use of the phrase "comprising one of the elements does not exclude the presence of other like elements in the process, method, article, or apparatus that comprises the element.

Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that changes, modifications, substitutions and alterations can be made in these embodiments without departing from the principles and spirit of the invention, the scope of which is defined in the appended claims and their equivalents.

Claims

1. A microcapsule smoothing toner is characterized by comprising 4% -6% of a beta-CD solution, 5% -7% of a plukenetia volubilis oil, 3% -9% of stearic acid, 2% -4% of hexadecanol, 5% -10% of isopropyl palmitate, 2% -6% of lanolin, 0.5% -2.5% of a jasmine extracting solution, 1% -3% of hyaluronic acid, 0.5% -1% of polyglutamic acid, 1% -3% of collagen, 0.05% -0.1% of essence, 0.2% -0.4% of urea aldehyde, 0.5% -2% of a cactus extracting solution, 2% -3% of an aloe extracting solution and the balance of deionized water.

2. The method for preparing a microencapsulated smoothing toner as claimed in claim 1, wherein the step S1 comprises preparing a β -CD solution, heating and stirring until the solution is completely dissolved;

step S3, weighing water phase raw materials and oil phase raw materials,

3. The method for preparing a microencapsulated smoothing toner according to claim 2, wherein the concentration of the β -CD solution is 15%.

4. The method of claim 2, wherein the stirring temperature of step S2 is 110 ℃.

5. The method of claim 2, wherein a preservative is added in step S4, and the preservative is hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer.

6. The method of claim 2, wherein an emulsifier is added in step S4, and the emulsifier is hydroxyethyl acrylate.